The Hikma Pharmaceuticals laboratory in Amman, Jordan. The company said that 6 per cent of its revenue last year was invested in research and development. Salah Malkawi / The National
The Hikma Pharmaceuticals laboratory in Amman, Jordan. The company said that 6 per cent of its revenue last year was invested in research and development. Salah Malkawi / The National

Hikma Pharmaceuticals' 2022 profit drops as 'competitive pressures' hit generics unit




Energy This Week

Expert analysis on oil & gas renewables and clean energy

      By signing up, I agree to The National's privacy policy
      Energy This Week